These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 33276103)
1. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Livshits G; Kalinkovich A Pharmacol Res; 2021 Feb; 164():105340. PubMed ID: 33276103 [TBL] [Abstract][Full Text] [Related]
2. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling. Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952 [TBL] [Abstract][Full Text] [Related]
3. New Horizons in the Treatment of Age-Associated Obesity, Sarcopenia and Osteoporosis. Kalinkovich A; Becker M; Livshits G Drugs Aging; 2022 Sep; 39(9):673-683. PubMed ID: 35781216 [TBL] [Abstract][Full Text] [Related]
4. Could Arachidonic Acid-Derived Pro-Resolving Mediators Be a New Therapeutic Strategy for Asthma Therapy? Insuela DBR; Ferrero MR; Coutinho DS; Martins MA; Carvalho VF Front Immunol; 2020; 11():580598. PubMed ID: 33362766 [TBL] [Abstract][Full Text] [Related]
6. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications. Wu B; Mottola G; Schaller M; Upchurch GR; Conte MS Mol Aspects Med; 2017 Dec; 58():72-82. PubMed ID: 28765077 [TBL] [Abstract][Full Text] [Related]
7. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives. Mastromarino M; Lacivita E; Colabufo NA; Leopoldo M Mini Rev Med Chem; 2020; 20(20):2090-2103. PubMed ID: 32682373 [TBL] [Abstract][Full Text] [Related]
12. Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases. Shang P; Zhang Y; Ma D; Hao Y; Wang X; Xin M; Zhang Y; Zhu M; Feng J Expert Opin Ther Targets; 2019 Nov; 23(11):967-986. PubMed ID: 31711309 [No Abstract] [Full Text] [Related]
13. Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice. Sharma P; Yi R; Nayak AP; Wang N; Tang F; Knight MJ; Pan S; Oliver B; Deshpande DA Sci Rep; 2017 Apr; 7():46166. PubMed ID: 28397820 [TBL] [Abstract][Full Text] [Related]
14. Novel anti-inflammatory--pro-resolving mediators and their receptors. Serhan CN; Krishnamoorthy S; Recchiuti A; Chiang N Curr Top Med Chem; 2011; 11(6):629-47. PubMed ID: 21261595 [TBL] [Abstract][Full Text] [Related]
15. Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development. Yang A; Wu Y; Yu G; Wang H Respir Res; 2021 Jul; 22(1):204. PubMed ID: 34261470 [TBL] [Abstract][Full Text] [Related]
16. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Chiang N; Serhan CN Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292 [TBL] [Abstract][Full Text] [Related]
17. Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice. Chen YF; Huang G; Wang YM; Cheng M; Zhu FF; Zhong JN; Gao YD Respir Res; 2019 Dec; 20(1):285. PubMed ID: 31852500 [TBL] [Abstract][Full Text] [Related]
18. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders. Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770 [TBL] [Abstract][Full Text] [Related]
19. Specialized Pro-Resolving Mediators and the Lymphatic System. Kraft JD; Blomgran R; Lundgaard I; Quiding-Järbrink M; Bromberg JS; Börgeson E Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803130 [TBL] [Abstract][Full Text] [Related]
20. Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation. Duvall MG; Bruggemann TR; Levy BD Mol Aspects Med; 2017 Dec; 58():44-56. PubMed ID: 28455109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]